Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction

Pain

Volumn 153, Issue 4, 2012, Pages 744-754

  Jarcho, Johanna M ^a,b   Mayer, Emeran A ^b   Jiang, Ziyue Karen ^c   Feier, Natasha A ^b   London, Edythe D ^b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Chronic pain; Depression; Dopamine; Drug abuse; Parkinson disease; Schizophrenia

Indexed keywords

ADRENALIN; AMISULPRIDE; APOMORPHINE; CATECHOL METHYLTRANSFERASE; COCAINE; DIAMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; ENKEPHALIN; HALOPERIDOL; LEVODOPA; METENKEPHALIN; METHAMPHETAMINE; MU OPIATE RECEPTOR; NEUROLEPTIC AGENT; NORADRENALIN; OPIATE RECEPTOR; POSTSYNAPTIC RECEPTOR; QUINPIROLE; RACLOPRIDE C 11; SFK 38393; UNCLASSIFIED DRUG;

ALCOHOLISM; AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; BRAIN DYSFUNCTION; BURNING MOUTH SYNDROME; CHRONIC PAIN; CINGULATE GYRUS; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CORPUS STRIATUM; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; FACE PAIN; FEEDBACK SYSTEM; FIBROMYALGIA; GENETIC ANALYSIS; HEROIN DEPENDENCE; HERPES ZOSTER; HIPPOCAMPUS; HUMAN; HYPERSENSITIVITY; MAJOR DEPRESSION; MOOD DISORDER; MOTOR ACTIVITY; NERVE CELL; NEUROANATOMY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN THRESHOLD; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYNAPSE; TOBACCO DEPENDENCE; UNSPECIFIED SIDE EFFECT;

EID: 84858702815     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.01.002     Document Type: Review

References (175)

1. E.D. Abercrombie, K.A. Keefe, D.S. DiFrischia, and M.J. Zigmond Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex J Neurochem 52 1989 1655 1658 (Pubitemid 19109526)
2. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L.S. Kegeles, R. Weiss, T.B. Cooper, J.J. Mann, R.L. Van Heertum, J.M. Gorman, and M. Laruelle Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci USA 97 2000 8104 8109 (Pubitemid 30460780)
3. P.H. Andersen, J.A. Gingrich, M.D. Bates, A. Dearry, P. Falardeau, S.E. Senogles, and M.G. Caron Dopamine receptor subtypes: beyond the D1/D2 classification Trends Pharmacol Sci 11 1990 231 236 (Pubitemid 20175416)
4. A.V. Apkarian, M.C. Bushnell, R.D. Treede, and J.K. Zubieta Human brain mechanisms of pain perception and regulation in health and disease Eur J Pain 9 2005 463 484 (Pubitemid 40836040)
5. A.V. Apkarian, Y. Sosa, B.R. Krauss, P.S. Thomas, B.E. Fredrickson, R.E. Levy, R.N. Harden, and D.R. Chialvo Chronic pain patients are impaired on an emotional decision-making task Pain 108 2004 129 136 (Pubitemid 38251682)
6. L. Atik, N. Konuk, O. Akay, D. Ozturk, and A. Erdogan Pain perception in patients with bipolar disorder and schizophrenia Acta Neuropsychiatr 19 2007 284
7. J. Axelrod, and R. Tomchick Enzymatic O-methylation of epinephrine and other catechols J Biol Chem 233 1958 702 705
8. K. Baicy, and E.D. London Corticolimbic dysregulation and chronic methamphetamine abuse Addiction 102 2007 5 15 (Pubitemid 46328215)
9. M.J. Bair, R.L. Robinson, W. Katon, and K. Kroenke Depression and pain comorbidity: a literature review Arch Intern Med 163 2003 2433 2445 (Pubitemid 37385786)
10. M.N. Baliki, P.Y. Geha, H.L. Fields, and A.V. Apkarian Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain Neuron 66 2010 149 160
11. A.G. Beiske, J.H. Loge, A. Rønningen, and E. Svensson Pain in Parkinson's disease: prevalence and characteristics Pain 141 2009 173 177
12. B. Berger, P. Gaspar, and C. Verney Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates Trends Neurosci 14 1991 21 27
13. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 1973 415 455
14. R.M. Bilder, J. Volavka, H.M. Lachman, and A.A. Grace The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes Neuropsychopharmacology 29 2004 1943 1961 (Pubitemid 39486546)
15. R. Blumensohn, D. Ringler, and I. Eli Pain perception in patients with schizophrenia J Nerv Ment Dis 190 2002 481 483 (Pubitemid 34815812)
16. D. Borsook, L. Becerra, W.A. Carlezon, M. Shaw, P. Renshaw, I. Elman, and J. Levine Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders Eur J Pain 11 2007 7 20 (Pubitemid 44740511)
17. A.L. Brody, M.A. Mandelkern, R.E. Olmstead, Z. Allen-Martinez, D. Scheibal, A.L. Abrams, M.R. Costello, J. Farahi, S. Saxena, J. Monterosso, and E.D. London Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette Neuropsychopharmacology 34 2009 282 289
18. A.R. Burkey, E. Carstens, and L. Jasmin Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception J Neurosci 19 1999 4169 4179 (Pubitemid 29222288)
19. R.M. Caldeiro, C.A. Malte, D.A. Calsyn, J.S. Baer, P. Nichol, D.R. Kivlahan, and A.J. Saxon The association of persistent pain with out-patient addiction treatment outcomes and service utilization Addiction 103 2008 1996 2005
20. D.M. Cannon, J.M. Klaver, S.A. Peck, D. Rallis-Voak, K. Erickson, and W.C. Drevets Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112 Neuropsychopharmacology 34 2009 1277 1287
21. A. Cerasa, M.C. Gioia, P. Tarantino, A. Labate, G. Arabia, G. Annesi, P. Lanza, G. Di Palma, V. Blasi, and A. Quattrone The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals Genes Brain Behav 8 2009 459 463
22. S. Cevoli, M. Mochi, C. Scapoli, N. Marzocchi, G. Pierangeli, L.A. Pini, P. Cortelli, and P. Montagna A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse Eur J Neurol 13 2006 1009 1013 (Pubitemid 44284910)
23. K.R. Chaudhuri, D.G. Healy, and A.H. Schapira National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurol 5 2006 235 245 (Pubitemid 43238347)
24. K.A. Cheon, Y.H. Ryu, J.W. Kim, and D.Y. Cho The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate Eur Neuropsychopharmacol 15 2005 95 101
25. Y.H. Chou, C. Halldin, and L. Farde Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study Synapse 38 2000 138 143
26. E.H. Chudler, and W.K. Dong The role of the basal ganglia in nociception and pain Pain 60 1995 3 38
27. U. Coffeen, A. López-Avila, J.M. Ortega-Legaspi, R. del Angel, F.J. López-Muñoz, and F. Pellicer Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat Eur J Pain 12 2008 535 543 (Pubitemid 351635555)
28. G. Crombez, J.W. Vlaeyen, P.H. Heuts, and R. Lysens Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability Pain 80 1999 329 339 (Pubitemid 29151718)
29. V. Czernecki, B. Pillon, J.L. Houeto, J.B. Pochon, R. Levy, and B. Dubois Motivation, reward, and Parkinson's disease: influence of dopatherapy Neuropsychologia 40 2002 2257 2267 (Pubitemid 35303365)
30. Y.H. Dang, Y. Zhao, B. Xing, X.J. Zhao, F.Q. Huo, J.S. Tang, C.L. Qu, and T. Chen The role of dopamine receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat model of neuropathic pain Neuroscience 169 2010 1872 1880
31. G. Defazio, A. Berardelli, G. Fabbrini, D. Martino, E. Fincati, A. Fiaschi, G. Moretto, G. Abbruzzese, R. Marchese, U. Bonuccelli, P. Del Dotto, P. Barone, E. De Vivo, A. Albanese, A. Antonini, M. Canesi, L. Lopiano, M. Zibetti, G. Nappi, E. Martignoni, P. Lamberti, and M. Tinazzi Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study Arch Neurol 65 2008 1191 1194
32. M. Del Zompo Dopaminergic hypersensitivity in migraine: clinical and genetic evidence Funct Neurol 15 2000 163 170 (Pubitemid 32051389)
33. G. Di Chiara, and A. Imperato Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats J Pharmacol Exp Ther 244 1988 1067 1080 (Pubitemid 18090131)
34. L. Diatchenko, G.D. Slade, A.G. Nackley, K. Bhalang, A. Sigurdsson, I. Belfer, D. Goldman, K. Xu, S.A. Shabalina, D. Shagin, M.B. Max, S.S. Makarov, and W. Maixner Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum Mol Genet 14 2005 135 143 (Pubitemid 40123469)
35. B.D. Dick, and S. Rashiq Disruption of attention and working memory traces in individuals with chronic pain Anesth Analg 104 2007 1223 1229 (Pubitemid 46649949)
36. R.P. Dickey, and J.P. Minton Levodopa relief of bone pain from breast cancer N Engl J Med 286 1972 843
37. B.W. Dunlop, and C.B. Nemeroff The role of dopamine in the pathophysiology of depression Arch Gen Psychiatry 64 2007 327 337 (Pubitemid 46376789)
38. R.H. Dworkin Pain insensitivity in schizophrenia: a neglected phenomenon and some implications Schizophr Bull 20 1994 235 248 (Pubitemid 24171084)
39. R.H. Dworkin, and M.J. Gitlin Clinical aspects of depression in chronic pain patients Clin J Pain 7 1991 79 94
40. U. Ehrt, J.P. Larsen, and D. Aarsland Pain and its relationship to depression in Parkinson disease Am J Geriatr Psychiatry 17 2009 269 275
41. M.A. Enoch, K. Xu, E. Ferro, C.R. Harris, and D. Goldman Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism Psychiatr Genet 13 2003 33 41 (Pubitemid 36293143)
42. M. Ertas, A. Sagduyu, N. Arac, B. Uludag, and C. Ertekin Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy Pain 75 1998 257 259 (Pubitemid 28160136)
43. J.P. Fadok, M. Darvas, T.M.K. Dickerson, and R.D. Palmiter Long-term memory for pavlovian fear conditioning requires dopamine in the nucleus accumbens and basolateral amygdala PLoS One 5 2010 e12751
44. H. Fields State-dependent opioid control of pain Nat Rev Neurosci 5 2004 565 575 (Pubitemid 38868552)
45. H.L. Fields Understanding how opioids contribute to reward and analgesia Reg Anesth Pain Med 32 2007 242 246 (Pubitemid 46818067)
46. D.A. Fishbain, R. Cutler, H.L. Rosomoff, and R.S. Rosomoff Chronic pain-associated depression: antecedent or consequence of chronic pain? A review Clin J Pain 13 1997 116 137 (Pubitemid 27251106)
47. S.B. Floresco, A.R. West, B. Ash, H. Moore, and A.A. Grace Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission Nat Neurosci 6 2003 968 973 (Pubitemid 37064759)
48. T. Foltynie, T.E. Goldberg, S.G. Lewis, A.D. Blackwell, B.S. Kolachana, D.R. Weinberger, T.W. Robbins, and R.A. Barker Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism Mov Disord 19 2004 885 891 (Pubitemid 39199254)
49. I.H. Franken Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches Prog Neuropsychopharmacol Biol Psychiatry 27 2003 563 579 (Pubitemid 36645055)
50. C. Garcia, R. Lynn, and W. Breitbart Psychotropic medications in palliative care Prim Psychiatry 16 2009 25 32
51. A. Gerdelat-Mas, M. Simonetta-Moreau, C. Thalamas, F. Ory-Magne, T. Slaoui, O. Rascol, and C. Brefel-Courbon Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study J Neurol Neurosurg Psychiatry 78 2007 1140 1142
52. N. Geschwind Insensitivity to pain in psychotic patients N Engl J Med 296 1977 1480 (Pubitemid 8175604)
53. A.A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia Neuroscience 41 1991 1 24
54. A.A. Grace, B.S. Bunney, H. Moore, and C.L. Todd Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs Trends Neurosci 20 1997 31 37 (Pubitemid 26421230)
55. O. Gureje, G.E. Simon, and M. Von Korff A cross-national study of the course of persistent pain in primary care Pain 92 2001 195 200 (Pubitemid 32367950)
56. S. Gürsoy, E. Erdal, H. Herken, E. Madenci, B. Alaehirli, and N. Erdal Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome Rheumatol Int 23 2003 104 107 (Pubitemid 36712983)
57. N. Hagelberg, H. Forssell, S. Aalto, J.O. Rinne, H. Scheinin, T. Taiminen, K. Ngren, O. Eskola, and S.K. Jääskeläinen Altered dopamine D2 receptor binding in atypical facial pain Pain 106 2003 43 48 (Pubitemid 37329612)
58. N. Hagelberg, H. Forssell, J.O. Rinne, H. Scheinin, T. Taiminen, S. Aalto, S. Luutonen, K. Ngren, and S. Jääskeläinen Striatal dopamine D1 and D2 receptors in burning mouth syndrome Pain 101 2003 149 154 (Pubitemid 36044662)
59. N. Hagelberg, I.K. Martikainen, H. Mansikka, S. Hinkka, K. Ngren, J. Hietala, H. Scheinin, and A. Pertovaara Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity Pain 99 2002 273 279 (Pubitemid 35247550)
60. H. Hall, G. Sedvall, O. Magnusson, J. Kopp, C. Halldin, and L. Farde Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain Neuropsychopharmacology 11 1994 245 256 (Pubitemid 24372813)
61. L. Haltia, J. Rinne, S. Helin, R. Parkkola, K. Ngren, and V. Kaasinen Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function Synapse 62 2008 682 688 (Pubitemid 352032543)
62. S.P. Hamilton, S.L. Slager, G.A. Heiman, Z. Deng, F. Haghighi, D.F. Klein, S.E. Hodge, M.M. Weissman, A.J. Fyer, and J.A. Knowles Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 Biol Psychiatry 51 2002 591 601 (Pubitemid 34327334)
63. R.P. Hart, M.F. Martelli, and N.D. Zasler Chronic pain and neuropsychological functioning Neuropsychol Rev 10 2000 131 149
64. D. Hasin, X. Liu, E. Nunes, S. McCloud, S. Samet, and J. Endicott Effects of major depression on remission and relapse of substance dependence Arch Gen Psychiatry 59 2002 375 380 (Pubitemid 34275256)
65. A. Heinz, D. Goldman, D.W. Jones, R. Palmour, D. Hommer, J.G. Gorey, K.S. Lee, M. Linnoila, and D.R. Weinberger Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 22 2000 133 139 (Pubitemid 30016015)
66. J.M. Hooley, and M.L. Delgado Pain insensitivity in the relatives of schizophrenia patients Schizophr Res 47 2001 265 273 (Pubitemid 32244111)
67. R. Horowitz, M. Kotler, E. Shufman, S. Aharoni, I. Kremer, H. Cohen, and R.P. Ebstein Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study Am J Med Genet 96 2000 599 603
68. J.C. Horvitz Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events Neuroscience 96 2000 651 656 (Pubitemid 30155729)
69. A. Hussar Leading causes of death in institutionalized chronic schizophrenic patients: a study of 1,275 autopsy protocols J Nerv Ment Dis 142 1966 45 57
70. T. Inoue, K. Tsuchiya, and T. Koyama Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain Pharmacol Biochem Behav 49 1994 911 920 (Pubitemid 24376030)
71. S.K. Jääskeläinen, J.O. Rinne, H. Forssell, O. Tenovuo, V. Kaasinen, P. Sonninen, and J. Bergman Role of the dopaminergic system in chronic pain - A fluorodopa-PET study Pain 90 2001 257 260 (Pubitemid 32162947)
72. T. Jochum, A. Letzsch, W. Greiner, G. Wagner, H. Sauer, and K.J. Bär Influence of antipsychotic medication on pain perception in schizophrenia Psychiatry Res 142 2006 151 156 (Pubitemid 43776567)
73. E.G. Jönsson, M.M. Nöthen, F. Grünhage, L. Farde, Y. Nakashima, P. Propping, and G.C. Sedvall Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers Mol Psychiatry 4 1999 290 296 (Pubitemid 29292183)
74. P.W. Kalivas, and P. Duffy Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress Brain Res 675 1995 325 328
75. S. Kernbaum, and J. Hauchecorne Administration of levodopa for relief of herpes zoster pain JAMA 246 1981 132 134 (Pubitemid 11122791)
76. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 2005 593 602 (Pubitemid 40973434)
77. S. Klauenberg, C. Maier, H. Assion, A. Hoffmann, E.K. Krumova, W. Magerl, A. Scherens, R.D. Treede, and G. Juckel Depression and changed pain perception: hints for a central disinhibition mechanism Pain 140 2008 332 343
78. M. Lantéri-Minet, F. Radat, M.-H. Chautard, and C. Lucas Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management Pain 118 2005 319 326 (Pubitemid 41752989)
79. S. Lapeyre, A. Mauborgne, C. Becker, J.J. Benoliel, F. Cesselin, M. Hamon, and S. Bourgoin Subcutaneous formalin enhances outflow of met-enkephalin- and cholecystokinin-like materials in the rat nucleus accumbens Naunyn Schmiedebergs Arch Pharmacol 363 2001 399 406 (Pubitemid 32247123)
80. M. Larson, M. Paasche-Orlow, D. Cheng, C. Lloyd-Travaglini, R. Saitz, and J. Samet Persistent pain is associated with substance use after detoxification: a prospective cohort analysis Addiction 102 2007 752 760 (Pubitemid 46633356)
81. M. Laruelle The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies Brain Res Rev 31 2000 371 384 (Pubitemid 30136193)
82. M. Laruelle, J. Gelernter, and R.B. Innis D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene Mol Psychiatry 3 1998 261 265 (Pubitemid 28266336)
83. M. Le Moal, and H. Simon Mesocorticolimbic dopaminergic network: functional and regulatory roles Physiol Rev 71 1991 155 234
84. B. Lee, E.D. London, R.A. Poldrack, J. Farahi, A. Nacca, J.R. Monterosso, J.A. Mumford, A.V. Bokarius, M. Dahlbom, J. Mukherjee, R.M. Bilder, A.L. Brody, and M.A. Mandelkern Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity J Neurosci 29 2009 14734 14740
85. M.A. Lee, R.W. Walker, T.J. Hildreth, and W.M. Prentice A survey of pain in idiopathic Parkinson's disease J Pain Symptom Manage 32 2006 462 469 (Pubitemid 44666294)
86. S. Leknes, and I. Tracey A common neurobiology for pain and pleasure Nat Rev Neurosci 9 2008 314 320 (Pubitemid 351430831)
87. P. Leone, D. Pocock, and R.A. Wise Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release Pharmacol Biochem Behav 39 1991 469 472
88. M.T. Lin, J.J. Wu, A. Chandra, and B.L. Tsay Activation of striatal dopamine receptors induces pain inhibition in rats J Neural Transm 51 1981 213 222 (Pubitemid 11040260)
89. S. Lissek, A.S. Powers, E.B. Mcclure, E.A. Phelps, G. Woldehawariat, C. Grillon, and D.S. Pine Classical fear conditioning in the anxiety disorders: a meta-analysis Behav Res Ther 43 2005 1391 1424 (Pubitemid 41282795)
90. T.B. Lonsdorf, A.I. Weike, P. Nikamo, M. Schalling, A.O. Hamm, and A. Ohman Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder Psychol Sci 20 2009 198 206
91. A. López-Avila, U. Coffeen, J.M. Ortega-Legaspi, R. del Angel, and F. Pellicer Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex Pain 111 2004 136 143 (Pubitemid 39141015)
92. T. Lotta, J. Vidgren, C. Tilgmann, I. Ulmanen, K. Melén, I. Julkunen, and J. Taskinen Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme Biochemistry 34 1995 4202 4210
93. A. Louilot, M. Le Moal, and H. Simon Differential reactivity of dopaminergic neurons in the nucleus accumbens in response to different behavioral situations. An in vivo voltammetric study in free moving rats Brain Res 397 1986 395 400
94. G. Magni, C. Moreschi, S. Rigatti-Luchini, and H. Merskey Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain Pain 56 1994 289 297 (Pubitemid 24087979)
95. J.E. Magnusson, and K. Fisher The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum Brain Res 855 2000 260 266 (Pubitemid 30085498)
96. G. Maina, A. Vitalucci, S. Gandolfo, and F. Bogetto Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study J Clin Psychiatry 63 2002 38 43 (Pubitemid 34113485)
97. W. Marchand, B. Sarota, H. Marble, T. Leary, C. Burbank, and M. Bellinger Occurrence of painless acute surgical disorders in psychotic patients N Engl J Med 260 1959 580 585
98. I.K. Martikainen, N. Hagelberg, H. Mansikka, J. Hietala, K. Ngren, H. Scheinin, and A. Pertovaara Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia Neurosci Lett 376 2005 149 153 (Pubitemid 40255300)
99. L.A. McWilliams, B.J. Cox, and M.W. Enns Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample Pain 106 2003 127 133 (Pubitemid 37329622)
100. M.A. Menza, D.E. Robertson-Hoffman, and A.S. Bonapace Parkinson's disease and anxiety: comorbidity with depression Biol Psychiatry 34 1993 465 470 (Pubitemid 23337729)
101. A. Meyer-Lindenberg, and D.R. Weinberger Intermediate phenotypes and genetic mechanisms of psychiatric disorders Nat Rev Neurosci 7 2006 818 827 (Pubitemid 44435264)
102. D. Mier, P. Kirsch, and A. Meyer-Lindenberg Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis Mol Psychiatry 15 2010 918 927
103. D. Miron, G.H. Duncan, and M.C. Bushnell Effects of attention on the intensity and unpleasantness of thermal pain Pain 39 1989 345 352 (Pubitemid 20029029)
104. H. Moore, C.L. Todd, and A.A. Grace Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons J Neurosci 18 1998 5068 5077 (Pubitemid 28285415)
105. A.G. Nackley, K.S. Tan, K. Fecho, P. Flood, L. Diatchenko, and W. Maixner Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors Pain 128 2007 199 208 (Pubitemid 46367417)
106. R. Narendran, N.S. Mason, C.-M. Chen, M. Himes, P. Keating, M.A. May, E.A. Rabiner, M. Laruelle, C.A. Mathis, and W.G. Frankle Evaluation of dopamine D(2/3) specific binding in the cerebellum for the PET radiotracer [(11) C]FLB 457: implications for measuring cortical dopamine release Synapse 65 2011 991 997
107. R. Narendran, N.S. Mason, M.A. May, C.-M. Chen, S. Kendro, K. Ridler, E.A. Rabiner, M. Laruelle, C.A. Mathis, and W.G. Frankle Positron emission tomography imaging of dopamine D2/3 receptors in the human cortex with [11C]FLB 457: reproducibility studies Synapse 65 2010 35 40
108. E.J. Nestler, and W.A. Carlezon The mesolimbic dopamine reward circuit in depression Biol Psychiatry 59 2006 1151 1159 (Pubitemid 44192421)
109. A. Nieoullon Dopamine and the regulation of cognition and attention Prog Neurobiol 67 2002 53 83 (Pubitemid 34786170)
110. E.P. Noble, K. Blum, T. Ritchie, A. Montgomery, and P.J. Sheridan Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism Arch Gen Psychiatry 48 1991 648 654
111. E.P. Noble, L.A. Gottschalk, J.H. Fallon, T.L. Ritchie, and J.C. Wu D2 dopamine receptor polymorphism and brain regional glucose metabolism Am J Med Genet 74 1997 162 166 (Pubitemid 27187645)
112. C.A. Olsson, R.J. Anney, M. Lotfi-Miri, G.B. Byrnes, R. Williamson, and G.C. Patton Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health Psychiatr Genet 15 2005 109 115 (Pubitemid 40806864)
113. A.D. Ong, A.J. Zautra, and M.C. Reid Psychological resilience predicts decreases in pain catastrophizing through positive emotions Psychol Aging 25 2010 516 523
114. L.M. Oswald, M. McCaul, L. Choi, X. Yang, and G.S. Wand Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report Biol Psychiatry 55 2003 102 105 (Pubitemid 38045440)
115. S.J. Peroutka Dopamine and migraine Neurology 49 1997 650 656 (Pubitemid 27427999)
116. G. Perrault, R. Depoortere, E. Morel, D.J. Sanger, and B. Scatton Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity J Pharmacol Exp Ther 280 1997 73 82 (Pubitemid 27171390)
117. A. Pertovaara, I.K. Martikainen, N. Hagelberg, H. Mansikka, K. Ngren, J. Hietala, and H. Scheinin Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain Eur J Neurosci 20 2004 1587 1592 (Pubitemid 39274041)
118. T. Pohjalainen, J.O. Rinne, K. Ngren, P. Lehikoinen, K. Anttila, E.K. Syvälahti, and J. Hietala The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers Mol Psychiatry 3 1998 256 260 (Pubitemid 28266335)
119. F.E. Pontieri, G. Tanda, and G. Di Chiara Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens Proc Natl Acad Sci USA 92 1995 12304 12308
120. L.J. Porrino, A.M. Crane, and P.S. Goldman-Rakic Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys J Comp Neurol 198 1981 121 136 (Pubitemid 11090650)
121. J. Potter, K. Prather, and R.D. Weiss Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities Am J Addict 17 2008 121 125 (Pubitemid 351507729)
122. S. Potvin, and S. Marchand Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies Pain 138 2008 70 78
123. J. Price, and W. Drevets Neurocircuitry of mood disorders Neuropsychopharmacology 35 2010 192 216
124. P.J. Quartana, C.M. Campbell, and R.R. Edwards Pain catastrophizing: a critical review Expert Rev Neurother 9 2009 745 758
125. N.P. Quinn, W.C. Koller, A.E. Lang, and C.D. Marsden Painful Parkinson's disease Lancet 1 1986 1366 1369 (Pubitemid 16121899)
126. B.H. Quittenbaum, and B. Grahn Quality of life and pain in Parkinson's disease: a controlled cross-sectional study Parkinsonism Relat Disord 10 2004 129 136 (Pubitemid 38251656)
127. J.L. Rhudy, and M.W. Meagher Fear and anxiety: divergent effects on human pain thresholds Pain 84 2000 65 75
128. F. Rico-Villademoros, J. Hidalgo, I. Dominguez, J.M. García-Leiva, and E.P. Calandre Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine Prog Neuropsychopharmacol Biol Psychiatry 29 2005 161 164 (Pubitemid 40021786)
129. T. Ritchie, and E.P. Noble Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics Neurochem Res 28 2003 73 82 (Pubitemid 36173228)
130. A.B. Rosenblatt, and N.A. Mekhail Management of pain in addicted/illicit and legal substance abusing patients Pain Pract 5 2005 2 10 (Pubitemid 41664180)
131. A. Rosenblum, H. Joseph, C. Fong, S. Kipnis, C. Cleland, and R.K. Portenoy Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities JAMA 289 2003 2370 2378 (Pubitemid 37430169)
132. S.H. Rosenthal, K.A. Porter, and B. Coffey Pain insensitivity in schizophrenia. Case report and review of the literature Gen Hosp Psychiatry 12 1990 319 322 (Pubitemid 20288615)
133. M.A. Sánchez-González, M.A. García-Cabezas, B. Rico, and C. Cavada The primate thalamus is a key target for brain dopamine J Neurosci 25 2005 6076 6083 (Pubitemid 40923474)
134. P. Schestatsky, H. Kumru, J. Valls-Solé, F. Valldeoriola, M.J. Marti, E. Tolosa, and M.L. Chaves Neurophysiologic study of central pain in patients with Parkinson disease Neurology 69 2007 2162 2169 (Pubitemid 350294696)
135. F.R. Schneier, M.R. Liebowitz, A. Abi-Dargham, Y. Zea-Ponce, S.H. Lin, and M. Laruelle Low dopamine D(2) receptor binding potential in social phobia Am J Psychiatry 157 2000 457 459 (Pubitemid 30145936)
136. H. Schoemaker, Y. Claustre, D. Fage, L. Rouquier, K. Chergui, O. Curet, A. Oblin, F. Gonon, C. Carter, J. Benavides, and B. Scatton Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity J Pharmacol Exp Ther 280 1997 83 97 (Pubitemid 27171391)
137. W. Schultz Multiple dopamine functions at different time courses Annu Rev Neurosci 30 2007 259 288 (Pubitemid 47218758)
138. W. Schultz Predictive reward signal of dopamine neurons J Neurophysiol 80 1998 1 27 (Pubitemid 28326237)
139. D.J. Scott, M.M. Heitzeg, R.A. Koeppe, C.S. Stohler, and J.K. Zubieta Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity J Neurosci 26 2006 10789 10795
140. D.J. Scott, C.S. Stohler, C.M. Egnatuk, H. Wang, R.A. Koeppe, and J.-K. Zubieta Individual differences in reward responding explain placebo-induced expectations and effects Neuron 55 2007 325 336 (Pubitemid 47048908)
141. D.J. Scott, C.S. Stohler, C.M. Egnatuk, H. Wang, R.A. Koeppe, and J.-K. Zubieta Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses Arch Gen Psychiatry 65 2008 220 231 (Pubitemid 351214321)
142. D.J. Scott, C.S. Stohler, R.A. Koeppe, and J.K. Zubieta Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge Synapse 61 2007 707 714 (Pubitemid 47122742)
143. S. Seidel, M. Aigner, M. Ossege, E. Pernicka, B. Wildner, and T. Sycha Antipsychotics for acute and chronic pain in adults J Pain Symptom Manage 39 2010 768 778
144. S.R. Sesack, V.A. Hawrylak, C. Matus, M.A. Guido, and A.I. Levey Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter J Neurosci 18 1998 2697 2708 (Pubitemid 28141815)
145. H.-Y. Sheng, C.-L. Qu, F.-Q. Huo, J.-Q. Du, and J.-S. Tang D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism Exp Neurol 215 2009 128 134
146. H. Simon, M. Le Moal, and A. Calas Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase Brain Res 178 1979 17 40 (Pubitemid 10241289)
147. R. Sinha How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158 2001 343 359 (Pubitemid 33141310)
148. B.W. Smith, D.G.V. Mitchell, M.G. Hardin, S. Jazbec, D. Fridberg, R.J.R. Blair, and M. Ernst Neural substrates of reward magnitude, probability, and risk during a wheel of fortune decision-making task Neuroimage 44 2009 600 609
149. M.N. Smolka, M. Bühler, G. Schumann, S. Klein, X.Z. Hu, M. Moayer, A. Zimmer, J. Wrase, H. Flor, K. Mann, D.F. Braus, D. Goldman, and A. Heinz Gene-gene effects on central processing of aversive stimuli Mol Psychiatry 12 2007 307 317 (Pubitemid 46328512)
150. R. Spanagel, A. Herz, and T.S. Shippenberg Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway Proc Natl Acad Sci USA 89 1992 2046 2050
151. W. Stamey, A. Davidson, and J. Jankovic Shoulder pain: a presenting symptom of Parkinson disease J Clin Rheumatol 14 2008 253 254
152. J. Tang, and S.J. Gibson A psychophysical evaluation of the relationship
153. N.K.Y. Tang, P.M. Salkovskis, A. Hodges, K.J. Wright, M. Hanna, and J. Hester Effects of mood on pain responses and pain tolerance: an experimental study in chronic back pain patients Pain 138 2008 392 401
154. B.K. Taylor, C. Joshi, and H. Uppal Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain Brain Res 987 2003 135 143 (Pubitemid 37281428)
155. K. Thorré, S. Sarre, I. Smolders, G. Ebinger, and Y. Michotte Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis Brain Res 796 1998 107 116 (Pubitemid 28343239)
156. J. Tiihonen, J. Kuikka, K. Bergström, U. Lepola, H. Koponen, and E. Leinonen Dopamine reuptake site densities in patients with social phobia Am J Psychiatry 154 1997 239 242 (Pubitemid 27053731)
157. J.A. Trafton, E.M. Oliva, D.A. Horst, J.D. Minkel, and K. Humphreys Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment Drug Alcohol Depend 73 2004 23 31 (Pubitemid 37542475)
158. R. Treister, D. Pud, R.P. Ebstein, E. Laiba, E. Gershon, M. Haddad, and E. Eisenberg Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans Pain 147 2009 187 193
159. E.M. Tunbridge, P.J. Harrison, and D.R. Weinberger Catechol-o- methyltransferase, cognition, and psychosis: Val158Met and beyond Biol Psychiatry 60 2006 141 151
160. E.M. van de Giessen, M.M. de Win, M.W. Tanck, W. van den Brink, F. Baas, and J. Booij Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3 J Nucl Med 50 2009 45 52
161. C.H. van Dyck, R.T. Malison, L.K. Jacobsen, J. Seibyl, J.K. Staley, M. Laruelle, R. Baldwin, R. Innis, and J. Gelernter Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene J Nucl Med 46 2005 745 751
162. D.J. Vandenbergh, L.A. Rodriguez, I.T. Miller, G.R. Uhl, and H.M. Lachman High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers Am J Med Genet 74 1997 439 442 (Pubitemid 27349382)
163. K. Verhoeven, G. Crombez, C. Eccleston, D.M. Van Ryckeghem, S. Morley, and S. Van Damme The role of motivation in distracting attention away from pain: an experimental study Pain 149 2010 229 234
164. N.D. Volkow, J.S. Fowler, G. Wang, and J. Swanson Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Mol Psychiatry 9 2004 557 569 (Pubitemid 38850435)
165. N.D. Volkow, J.S. Fowler, G.J. Wang, R. Hitzemann, J. Logan, D.J. Schlyer, S.L. Dewey, and A.P. Wolf Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers Synapse 14 1993 169 177 (Pubitemid 23157765)
166. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, D. Schlyer, R. Hitzemann, J. Lieberman, B. Angrist, N. Pappas, and R. MacGregor Imaging endogenous dopamine competition with [11C]raclopride in the human brain Synapse 16 1994 255 262 (Pubitemid 24111524)
167. N.D. Volkow, G.J. Wang, F. Telang, J.S. Fowler, J. Logan, M. Jayne, Y. Ma, K. Pradhan, and C. Wong Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement J Neurosci 27 2007 12700 12706 (Pubitemid 350127825)
168. C.H. Williams-Gray, A. Hampshire, R.A. Barker, and A.M. Owen Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype Brain 131 2008 397 408 (Pubitemid 351197617)
169. J.-M. Woo, K.-S. Yoon, Y.-H. Choi, K.-S. Oh, Y.-S. Lee, and B.-H. Yu The association between panic disorder and the L/L genotype of catechol-O- methyltransferase J Psychiatr Res 38 2004 365 370 (Pubitemid 38760003)
170. P.B. Wood, J.C. Patterson, J.J. Sunderland, K.H. Tainter, M.F. Glabus, and D.L. Lilien Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study J Pain 8 2007 51 58 (Pubitemid 46026964)
171. P.B. Wood, P. Schweinhardt, E. Jaeger, A. Dagher, H. Hakyemez, E.A. Rabiner, M.C. Bushnell, and B.A. Chizh Fibromyalgia patients show an abnormal dopamine response to pain Eur J Neurosci 25 2007 3576 3582 (Pubitemid 47020461)
172. N.D. Woodward, D.H. Zald, Z. Ding, P. Riccardi, M.S. Ansari, R.M. Baldwin, R.L. Cowan, R. Li, and R.M. Kessler Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study Neuroimage 46 2009 31 38
173. D.H. Zald, N.D. Woodward, R.L. Cowan, P. Riccardi, M.S. Ansari, R.M. Baldwin, R.L. Cowan, C.E. Smith, H. Hakyemez, R. Li, and R.M. Kessler The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding Neuroimage 51 2010 53 62
174. J.K. Zubieta, M.M. Heitzeg, Y.R. Smith, J.A. Bueller, K. Xu, Y. Xu, R.A. Koeppe, C.S. Stohler, and D. Goldman COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor Science 299 2003 1240 1243 (Pubitemid 36237467)
175. J.K. Zubieta, Y.R. Smith, J.A. Bueller, Y. Xu, M.R. Kilbourn, D.M. Jewett, C.R. Meyer, R.A. Koeppe, and C.S. Stohler Regional mu opioid receptor regulation of sensory and affective dimensions of pain Science 293 2001 311 315 (Pubitemid 32694749)